Figler R A, Omote H, Nakamoto R K, Al-Shawi M K
Department of Molecular Physiology, University of Virginia Health Sciences Center, Charlottesville, Virginia, 22908-0736, USA.
Arch Biochem Biophys. 2000 Apr 1;376(1):34-46. doi: 10.1006/abbi.2000.1712.
Utilizing human P-glycoprotein (P-gp), we investigated methods to enhance the heterologous expression of ATP-binding cassette transporters in Saccharomyces cerevisiae. Human multidrug resistance gene MDR1 cDNA was placed in a high-copy 2 mu yeast expression plasmid under the control of the inducible GAL1 promoter or the strong constitutive PMA1 promoter from which P-gp was expressed in functional form. Yeast cells expressing P-gp were valinomycin resistant. Basal ATPase activity of P-gp in yeast membranes was 0. 4-0.7 micromol/mg/min indicating excellent functionality. P-glycoprotein expressed in the protease-deficient strain BJ5457 was found in the plasma membrane and was not N-glycosylated. By use of the PMA1 promoter, P-gp could be expressed at 3% of total membrane protein. The expression level could be further enhanced to 8% when cells were grown in the presence of 10% glycerol as a chemical chaperone. Similarly, glycerol enhanced protein levels of P-gp expressed under control of the GAL1 promoter. Glycerol was demonstrated to enhance posttranslational stability of P-gp. Polyhistidine-tagged P-gp was purified by metal affinity chromatography and reconstituted into proteoliposomes in milligram quantities and its ATPase activity was characterized. Turnover numbers as high as 12 s(-1) were observed. The kinetic parameters K(MgATP)(M), V(max), and drug activation were dependent on the lipid composition of proteoliposomes and pH of the assay and were similar to P-gp purified from mammalian sources. In conclusion, we developed a system for cost-effective, high-yield, heterologous expression of functional P-gp useful in producing large quantities of normal and mutant P-gp forms for structural and mechanistic studies.
我们利用人P-糖蛋白(P-gp)研究了增强酿酒酵母中ATP结合盒转运蛋白异源表达的方法。人多药耐药基因MDR1 cDNA被置于高拷贝2μm酵母表达质粒中,受诱导型GAL1启动子或强组成型PMA1启动子的控制,P-gp以功能形式从该启动子表达。表达P-gp的酵母细胞对缬氨霉素具有抗性。酵母膜中P-gp的基础ATP酶活性为0.4 - 0.7微摩尔/毫克/分钟,表明其功能良好。在蛋白酶缺陷型菌株BJ5457中表达的P-糖蛋白存在于质膜中,且未进行N-糖基化。通过使用PMA1启动子,P-gp可表达至总膜蛋白的3%。当细胞在作为化学伴侣的10%甘油存在下生长时,表达水平可进一步提高至8%。同样,甘油增强了在GAL1启动子控制下表达的P-gp的蛋白水平。已证明甘油可增强P-gp的翻译后稳定性。带有多聚组氨酸标签的P-gp通过金属亲和层析纯化,并以毫克量重组成蛋白脂质体,对其ATP酶活性进行了表征。观察到高达12 s⁻¹的周转数。动力学参数K(MgATP)(M)、V(max)和药物激活取决于蛋白脂质体的脂质组成和测定的pH值,与从哺乳动物来源纯化的P-gp相似。总之,我们开发了一种系统,用于功能性P-gp的经济高效、高产异源表达,这有助于大量生产正常和突变形式的P-gp用于结构和机制研究。